인후두 역류증의 약물요법에 적절한 약제 및 치료기간의 선택
Optimal Regimen and Period for the Treatment of Patients with Laryngopharyngeal Reflux Disease
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Background and Objectives Various drugs can be used for treatment of laryngopharyngeal reflux disease (LPRD). However, the optimal medical treatment regimen is still controversial. This study was performed to determine the optimal medical treatment regimen and duration for LPRD. Subjects and Method We studied 172 patients who were diagnosed as LPRD by reflux symptom index (RSI) or reflux finding scores (RFS). The study group was divided into 4 groups according to the medication regimen: proton pump inhibitor (PPI), PPI and prokinetics, PPI and H2 blocker, and double dose PPI groups. All patients took medicines for 3 months or more. Clinical remission was defined as 70% improvement of initial RSI scores. Results 36 (20.9%) patients were prescribed PPI only, 65 (37.8%) patients PPI with prokinetics, 51 (29.6%) patients PPI with H2 blocker, 20 (11.6%) patients double dose PPI. Pretreatment with RSI and RFS did not differ among the four groups. RSI was improved after one month of medication in all of the groups. RSI and RFS tended to decrease during the treatment in all groups (p for trend ＜0.001). The mean clinical remission time was 2.3 months in patients receiving PPI alone, 2.6 months in PPI and prokinetics group, 2.5 months in the PPI and H2 blocker group and 1.8 months in the double dose PPI group. About 70% of patients reached clinical remission within 3 months. Conclusion PPI with or without prokinetics or H2 blocker is effective treatment for LPRD, and the appropriate duration of medication seems to be about 3 months. Double dose PPI can be used for those whom normal dose PPI is ineffective. Korean J Otorhinolaryngol-Head Neck Surg 2014;57(10):698-702
Abstract
Background and Objectives Various drugs can be used for treatment of laryngopharyngeal reflux disease (LPRD). However, the optimal medical treatment regimen is still controversial. This study was performed to determine the optimal medical treatment regimen and duration for LPRD. Subjects and Method We studied 172 patients who were diagnosed as LPRD by reflux symptom index (RSI) or reflux finding scores (RFS). The study group was divided into 4 groups according to the medication regimen: proton pump inhibitor (PPI), PPI and prokinetics, PPI and H2 blocker, and double dose PPI groups. All patients took medicines for 3 months or more. Clinical remission was defined as 70% improvement of initial RSI scores. Results 36 (20.9%) patients were prescribed PPI only, 65 (37.8%) patients PPI with prokinetics, 51 (29.6%) patients PPI with H2 blocker, 20 (11.6%) patients double dose PPI. Pretreatment with RSI and RFS did not differ among the four groups. RSI was improved after one month of medication in all of the groups. RSI and RFS tended to decrease during the treatment in all groups (p for trend ＜0.001). The mean clinical remission time was 2.3 months in patients receiving PPI alone, 2.6 months in PPI and prokinetics group, 2.5 months in the PPI and H2 blocker group and 1.8 months in the double dose PPI group. About 70% of patients reached clinical remission within 3 months. Conclusion PPI with or without prokinetics or H2 blocker is effective treatment for LPRD, and the appropriate duration of medication seems to be about 3 months. Double dose PPI can be used for those whom normal dose PPI is ineffective. Korean J Otorhinolaryngol-Head Neck Surg 2014;57(10):698-702
참고문헌 (20)
- Schreiber S, "Pathophysiological mechanisms of extraesophageal reflux in otolaryngeal disorders", Eur Arch Otorhinolaryngol, 266(1), pp.17~24 (2009)
- Shin KS, "The role of psychological distress in laryngopharyngeal reflux patients:a prospective questionnaire study", Clin Otolaryngol, 35(1), pp.25~30 (2010)
- Laryngopharyngeal reflux disease. The 2ND digestive disease research lecture, "Choi HS", Korea University Digestive research institute, ~ (1999)
- 오재호, "인후두 역류질환에서 24시간 이중 탐침 산도 검사와 Reflux Finding Score, Reflux Symptom Index의 연관성", 대한이비인후과학회지 두경부외과학, 56(11), pp.706~710 (2013), 대한이비인후과학회[DOI]
- 태경, "인후두역류증의 진단：식도점막 생검의 의의", 대한이비인후과학회지 두경부외과학, 49(1), pp.79~84 (2006), 대한이비인후과학회
- Ford CN, "Evaluation and management of laryngopharyngeal reflux", JAMA, 294(12), pp.1534~1540 (2005)
- Belafsky PC, "The validity and reliability of the reflux finding score (RFS)", Laryngoscope, 111(8), pp.1313~1317 (2001)
- Berardi RR, "A critical evaluation of proton pump inhibitors in the treatment of gastroesophageal reflux disease", Am J Manag Care, 6(9 Suppl), pp.S491~S505 (2000)
- Barry DW, "Laryngopharyngeal reflux: More questions than answers", Cleve Clin J Med, 77(5), pp.327~334 (2010)
- Choi HS, "Efficacy profile of cisapride in laryngopharyngeal reflux (LPR)-related symptoms (open multicenter case study & open multicenter case study between cisapride & ranitidine)", J Korean Logo Phon, 9(2), pp.115~127 (1998)
- Hsu YC, "Mosapride as an adjunct to lansoprazole for symptom relief of reflux oesophagitis", Br J Clin Pharmacol, 70(2), pp.171~179 (2010)
- Tutuian R, "Effects of a 5-HT(4) receptor agonist on oesophageal function and gastro-oesophageal reflux: studies using combined impedance-manometry and combined impedance-pH", Aliment Pharmacol Ther, 24(1), pp.155~162 (2006)
- Park W, "Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response", Laryngoscope, 115(7), pp.1230~1238 (2005)
- Fackler WK, "Long-term effect of H2RA therapy on nocturnal gastric acid breakthrough", Gastroenterology, 122(3), pp.625~632 (2002)
- Castell DO, "Future medical therapy of reflux esophagitis", J Clin Gastroenterol, 8(Suppl 1), pp.81~85 (1986)
- Belafsky PC, "Laryngopharyngeal reflux symptoms improve before changes in physical findings", Laryngoscope, 111(6), pp.976~981 (2001)
- 안철민, "역류성 후두염에 있어 Ranitidine과 Rabeprazole의 효과에 관한 비교 연구", 대한이비인후과학회지 두경부외과학, 46(6), pp.513~519 (2003), 대한이비인후과학회
- Tae K, "The changes of reflux symptoms and laryngoscopic findings in treatment of patients with laryngopharyngeal reflux", J Korean Logo Phon, 16(1), pp.15~18 (2005)
- 정만기, "인후두 역류증에 대한 초치료로서 양성자 펌프 억제제4주 단기 치료의 효과", 대한이비인후과학회지 두경부외과학, 48(6), pp.796~800 (2005), 대한이비인후과학회
- 김광하, "위식도역류질환의 식도 외 증상", 대한소화기학회지, 52(2), pp.69~79 (2008), 대한소화기학회